Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potassium channels as tumour markers

31 Mar 2006

Abstract excerpt

An increasing number of ion channels are being found to be causally involved in diseases, giving rise to the new field of "channelopathies". Cancer is no exception, and several ion channels have been linked to tumour progression. Among them is the potassium channel EAG (Ether-a-go-go). Over 75% of tumours have been tested positive using a monoclonal antibody specific for EAG, while inhibition of this channel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac electrophysiology and arrhythmias
Share to Ion channel regulation and function
Share to Neuroscience and Neuropharmacology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16783874
DOI: 10.1016/j.febslet.2006.03.062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potassium channels as tumour markersPMID 16783874Read ↗

HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential.Semantic proximity Read ↗

Oncogenic potential of EAG K(+) channels.Semantic proximity Read ↗

Targeting Ion Channels in Cancer: A Novel Frontier in Antineoplastic TherapySemantic proximity Read ↗

Ether a go-go Potassium Channels as Human Cervical Cancer MarkersSemantic proximity Read ↗

Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatmentSemantic proximity Read ↗

Targeting potassium channels in cancerSemantic proximity Read ↗

Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype.Semantic proximity Read ↗

Targeting the Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and PreventionSemantic proximity Read ↗

Impact of intracellular ion channels on cancer development and progressionSemantic proximity Read ↗

Involvement of potassium channels in the progression of cancer to a more malignant phenotype.Semantic proximity Read ↗

News and views on ion channels in cancer: is cancer a channelopathy?Semantic proximity Read ↗

Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.